menu
    • menu

    Company profile for Leads Biolabs

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Leads Biolabs is a clinical-stage biopharmaceutical company founded in Nanjing by a senior antibody drug research and development team studying in the United States. The company's research focuses on tumor immunotherapy antibody projects and drugs for cancer treatments, enabling patients to receive tumor and cancer medical treatment and support, improving their conditions. On the single-target antibody and bispecific antibody ...
    Leads Biolabs is a clinical-stage biopharmaceutical company founded in Nanjing by a senior antibody drug research and development team studying in the United States. The company's research focuses on tumor immunotherapy antibody projects and drugs for cancer treatments, enabling patients to receive tumor and cancer medical treatment and support, improving their conditions. On the single-target antibody and bispecific antibody new drug R&D technology platform, the company already has a rich R&D pipeline consisting of more than 20 new tumor immunotherapy antibody projects.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Leads BiolabsChina Flag
    Country
    Country
    China
    Address
    Address
    8th Floor, Building 3, No. 18, Jialingjiang East Street, Jianye District
    Telephone
    Telephone
    +86 02583378099
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.leadsbiolabs.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dianthus Therapeutics Licenses DNTH212, To Leads Biolabs
    Dianthus Therapeutics Licenses DNTH212, To Leads Biolabs

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/16/3167762/0/en/Dianthus-Therapeutics-Announces-Exclusive-License-Agreement-with-Leads-Biolabs-for-DNTH212-a-First-and-Potentially-Best-In-Class-Phase-1-Ready-Bifunctional-BDCA2-BAFF-APRIL-Inhibit.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share
    FDA Clears IND Application for LBL-047 by Leads Biolabs
    FDA Clears IND Application for LBL-047 by Leads Biolabs

    22 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/first-in-class-potential-fda-clears-ind-application-for-lbl-047-an-anti-bdca2taci-bispecific-fusion-protein-developed-by-leads-biolabs-302562528.html

    PR NEWSWIRE
    22 Sep 2025
    Share Share
    First Patient Dosed in Opamtistomig's Melanoma Phase 1b/II Trial
    First Patient Dosed in Opamtistomig's Melanoma Phase 1b/II Trial

    12 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/indication-expansion-accelerates-first-patient-dosed-in-melanoma-phase-1bii-trial-of-opamtistomig-302554826.html

    PR NEWSWIRE
    12 Sep 2025
    Share Share
    Leads Biolabs Doses First Patient In Ph2 Trial Of LBL-034
    Leads Biolabs Doses First Patient In Ph2 Trial Of LBL-034

    25 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/acceleration-in-clinical-development-leads-biolabs-lbl-034-dosed-first-patient-in-phase--trial-302537572.html

    PR NEWSWIRE
    25 Aug 2025
    Share Share
    Leads Biolabs Completes Patient Enrollment in Opamtistomig Trial
    Leads Biolabs Completes Patient Enrollment in Opamtistomig Trial

    14 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/leads-biolabs-announces-completion-of-patient-enrollment-in-pivotal-trial-of-opamtistomig-monotherapy-for-extrapulmonary-neuroendocrine-carcinoma-302530006.html

    PR NEWSWIRE
    14 Aug 2025
    Share Share
    Leads Biolabs Hits Hong Kong Stock Exchange in $189 M IPO
    Leads Biolabs Hits Hong Kong Stock Exchange in $189 M IPO

    25 Jul 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/chinese-antibody-developer-leads-biolabs-hits-hong-kong-stock-exchange-189m-ipo

    FIERCE BIOTECH
    25 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search